- Home
- IKNA vs SST Comparison
IKNA vs SST Comparison
Compare IKNA & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- SST
- Stock Information
- Founded
- IKNA 2016
- SST 2013
- Country
- IKNA United States
- SST United States
- Employees
- IKNA N/A
- SST N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- SST Diversified Commercial Services
- Sector
- IKNA Health Care
- SST Consumer Discretionary
- Exchange
- IKNA Nasdaq
- SST Nasdaq
- Market Cap
- IKNA 81.6M
- SST 67.8M
- IPO Year
- IKNA 2021
- SST N/A
- Fundamental
- Price
- IKNA $1.45
- SST $0.68
- Analyst Decision
- IKNA Buy
- SST Hold
- Analyst Count
- IKNA 2
- SST 1
- Target Price
- IKNA $3.00
- SST $2.00
- AVG Volume (30 Days)
- IKNA 134.5K
- SST 1.2M
- Earning Date
- IKNA 03-11-2025
- SST 03-17-2025
- Dividend Yield
- IKNA N/A
- SST N/A
- EPS Growth
- IKNA N/A
- SST N/A
- EPS
- IKNA N/A
- SST N/A
- Revenue
- IKNA $659,000.00
- SST $364,450,000.00
- Revenue This Year
- IKNA N/A
- SST N/A
- Revenue Next Year
- IKNA N/A
- SST $2.59
- P/E Ratio
- IKNA N/A
- SST N/A
- Revenue Growth
- IKNA N/A
- SST N/A
- 52 Week Low
- IKNA $1.22
- SST $0.60
- 52 Week High
- IKNA $1.94
- SST $2.73
- Technical
- Relative Strength Index (RSI)
- IKNA 36.12
- SST 36.62
- Support Level
- IKNA $1.45
- SST $0.63
- Resistance Level
- IKNA $1.53
- SST $0.74
- Average True Range (ATR)
- IKNA 0.06
- SST 0.11
- MACD
- IKNA -0.00
- SST -0.01
- Stochastic Oscillator
- IKNA 23.53
- SST 1.40
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment.